FI50119B - - Google Patents

Info

Publication number
FI50119B
FI50119B FI659/69A FI65969A FI50119B FI 50119 B FI50119 B FI 50119B FI 659/69 A FI659/69 A FI 659/69A FI 65969 A FI65969 A FI 65969A FI 50119 B FI50119 B FI 50119B
Authority
FI
Finland
Application number
FI659/69A
Other languages
Finnish (fi)
Other versions
FI50119C (fi
Inventor
Laszlo Beregi
Pierre Hugon
Michel Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Application granted granted Critical
Publication of FI50119B publication Critical patent/FI50119B/fi
Publication of FI50119C publication Critical patent/FI50119C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FI690659A 1968-03-06 1969-03-05 Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi. FI50119C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB00906/68A GB1203691A (en) 1968-03-06 1968-03-06 New disubstituted n-amino indoline derivatives and process for preparing them

Publications (2)

Publication Number Publication Date
FI50119B true FI50119B (id) 1975-09-01
FI50119C FI50119C (fi) 1975-12-10

Family

ID=9976474

Family Applications (1)

Application Number Title Priority Date Filing Date
FI690659A FI50119C (fi) 1968-03-06 1969-03-05 Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi.

Country Status (13)

Country Link
US (1) US3565911A (id)
BE (1) BE728658A (id)
CH (1) CH507940A (id)
DE (1) DE1909180A1 (id)
DK (1) DK126193B (id)
ES (1) ES364421A1 (id)
FI (1) FI50119C (id)
FR (1) FR2003311A1 (id)
GB (1) GB1203691A (id)
IT (1) IT8049196A0 (id)
NL (1) NL145226B (id)
NO (1) NO128068B (id)
SE (1) SE334887B (id)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112111A (en) * 1975-02-26 1978-09-05 Sandoz Ltd. Indolinylguanidines
IT1113879B (it) * 1979-03-15 1986-01-27 Farmatis Spa Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
LU82949A1 (fr) * 1980-11-20 1981-06-04 Usv Pharma Corp Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension
DE3172386D1 (en) * 1980-12-22 1985-10-24 Usv Pharma Corp Synthesis of indolines
JPS57206657A (en) * 1981-06-16 1982-12-18 Mitsui Toatsu Chem Inc Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
FR2663325B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique.
FR2663324B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
JP2008520578A (ja) * 2004-11-15 2008-06-19 ニトロメッド インコーポレーティッド 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
FR2924713B1 (fr) * 2007-12-11 2010-01-29 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2011149438A1 (en) 2010-05-28 2011-12-01 Mahmut Bilgic Combination of antihypertensive agents
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso
TW202314018A (zh) * 2021-06-21 2023-04-01 荷蘭商Asm Ip私人控股有限公司 用於形成包含氧化銦鎵鋅的層之反應器系統及方法
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide
EP4374855A1 (en) 2022-11-22 2024-05-29 KRKA, D.D., Novo Mesto Pharmaceutical dosage form of candesartan and indapamide

Also Published As

Publication number Publication date
IT8049196A0 (it) 1980-07-09
ES364421A1 (es) 1971-02-01
BE728658A (id) 1969-08-19
SE334887B (id) 1971-05-10
CH507940A (fr) 1971-05-31
NL145226B (nl) 1975-03-17
NL6903421A (id) 1969-09-09
GB1203691A (en) 1970-09-03
FI50119C (fi) 1975-12-10
FR2003311A1 (id) 1969-11-07
US3565911A (en) 1971-02-23
NO128068B (id) 1973-09-24
DK126193B (da) 1973-06-18
DE1909180A1 (de) 1970-07-02

Similar Documents

Publication Publication Date Title
AU1946070A (id)
FI50119B (id)
AU5506869A (id)
AU2374870A (id)
AU5184069A (id)
AU6168869A (id)
AU6171569A (id)
AU416157B2 (id)
AU2952567A (id)
AU2581067A (id)
AU4811568A (id)
AU2580267A (id)
AR203075Q (id)
AU3789668A (id)
AU3224368A (id)
AU4744468A (id)
BE728090A (id)
BE727796A (id)
BE630165A (id)
BE642636A (id)
BE708888A (id)
BE728379A (id)
BE728296A (id)
AU463027A (id)
AU479393A (id)